Home » Headlines » Currently Reading:

Morning Headlines 7/18/23

July 17, 2023 Headlines No Comments

Thoma Bravo Announces Strategic Growth Investment in Bluesight to Support the Company’s Acquisition of Medacist

Medication supply chain technology company Bluesight will use a strategic growth investment from Thoma Bravo in its acquisition of Medacist, a drug diversion monitoring and medication management software vendor.

Unicorn K Health raises $59 million in down round

Israeli digital primary care startup K Health raises $59 million in a funding round led by Cedars-Sinai.

These Chicago execs want their fraud convictions overturned. Here’s their argument.

Outcome Health co-founders Rishi Shah and Shradha Agarwal want their fraud convictions overturned based on the argument that prosecutors seized more of their assets than was warranted before trial, leaving them unable to employ their first-pick attorneys.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. HCAT / Upfront acquisition. This is a classic public company play when your revenue/profits/stock are declining. Making an acquisition can…

  2. Regarding MultiPlan, doctors and hospitals cannot compare prices; it's collusion. Why is it not collusion when the insurers do it?…

  3. I get my healthcare at one of the participating sites. For 6-8 months, they've been pushing free genetic testing. There…

  4. The UHC hiding the breach notice page is one thing but it looks like Nebraska is suing Change Healthcare for…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.